Internal Medicine Alert – June 15, 2008
June 15, 2008
View Issues
-
Omega-3 Free Fatty Acids for the Maintenance of Remission in Crohn's Disease
Despite previous positive reports and much lay enthusiasm, omega-3 fatty acid treatment did not prevent Crohn's disease relapse. (Arguments continue as to whether the correct usage should be "Crohn disease" or "Crohn's disease." Most of the literature seems to use the latter designation, and this review will do likewise.) -
Prevalence of Widespread Cognitive Impairments in the Elderly
Cognitive impairment in the U.S. population without dementia is found in 22% of those over age 70. This is more than the number of those with Alzheimer's or other dementias alone, and needs to be recognized and addressed in our healthcare of this group. -
Increased Incidence of Pneumonia in Elderly Patients on Antipsychotics
Current use of antipsychotic medications by the elderly places them at increased risk for hospitalization for pneumonia. -
Regadenoson Injection (Lexiscan™)
Regadenoson, the first selective A2A adenosine receptor agonist, has been approved for use as a pharmacologic stress agent for nuclear medicine stress testing (radionuclide myocardial perfusion imaging). -
Clinical Briefs by Louis Kuritzky, MD
Because the consequence of missed pulmonary embolism (PEM) is so grave, it is essential to continue our evolution of tools which maximize diagnostic sensitivity, offer clinical expedience, and minimize risk for the patient. -
ECG Review: What are the 5 Findings?
12-lead ECG and lead II rhythm strip obtained from a 67-year-old man with new-onset shortness of breath. -
Pharmacology Watch
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions